BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19638274)

  • 41. Evidence for common structural changes in thrombin induced by active-site or exosite binding.
    Parry MA; Stone SR; Hofsteenge J; Jackman MP
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):665-70. PubMed ID: 8457193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
    Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
    Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR; Bock PE
    Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.
    Li W; Adams TE; Nangalia J; Esmon CT; Huntington JA
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4661-6. PubMed ID: 18362344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions.
    Pozzi N; Acquasaliente L; Frasson R; Cristiani A; Moro S; Banzato A; Pengo V; Scaglione GL; Arcovito A; De Cristofaro R; De Filippis V
    J Thromb Haemost; 2013 Jun; 11(6):1093-102. PubMed ID: 23578283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
    Han JH; Tollefsen DM
    Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
    Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the possible recognition sites for thrombomodulin, procoagulant, and anticoagulant proteins around the active center of alpha-thrombin.
    Nishioka J; Taneda H; Suzuki K
    J Biochem; 1993 Jul; 114(1):148-55. PubMed ID: 8407867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site-specific dissection of substrate recognition by thrombin.
    Vindigni A; Dang QD; Di Cera E
    Nat Biotechnol; 1997 Sep; 15(9):891-5. PubMed ID: 9306406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II.
    Sabo TM; Maurer MC
    Biochemistry; 2009 Aug; 48(30):7110-22. PubMed ID: 19591434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin.
    Fortenberry YM; Whinna HC; Cooper ST; Myles T; Leung LL; Church FC
    J Thromb Haemost; 2007 Jul; 5(7):1486-92. PubMed ID: 17635698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a thrombin-binding region in the sixth epidermal growth factor-like repeat of human thrombomodulin.
    Tolkatchev D; Ng A; Zhu B; Ni F
    Biochemistry; 2000 Aug; 39(34):10365-72. PubMed ID: 10956026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
    Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
    Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for allosteric linkage between exosites 1 and 2 of thrombin.
    Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1997 Oct; 272(41):25493-9. PubMed ID: 9325262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.
    Claeson G
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):411-36. PubMed ID: 8075312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.
    Nimjee SM; Oney S; Volovyk Z; Bompiani KM; Long SB; Hoffman M; Sullenger BA
    RNA; 2009 Dec; 15(12):2105-11. PubMed ID: 19846574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
    Anderson PJ; Bock PE
    J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
    Anderson PJ; Nesset A; Bock PE
    J Biol Chem; 2003 Nov; 278(45):44482-8. PubMed ID: 12939269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The determination of protonation states in proteins.
    Ahmed HU; Blakeley MP; Cianci M; Cruickshank DW; Hubbard JA; Helliwell JR
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):906-22. PubMed ID: 17642517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.